Review: sporadic cerebral amyloid angiopathy.

作者: J. Attems , K. Jellinger , D. R. Thal , W. Van Nostrand

DOI: 10.1111/J.1365-2990.2010.01137.X

关键词:

摘要: Cerebral amyloid angiopathy (CAA) may result from focal to widespread amyloid-β protein (Aβ) deposition within leptomeningeal and intracortical cerebral blood vessels. In addition, pericapillary Aβ refers depositions in the glia limitans adjacent neuropil, whereas capillary CAA are present wall. cause lobar intracerebral haemorrhages microbleeds. Hypoperfusion reduced vascular autoregulation due might infarcts white matter lesions. thus causes lesions that potentially lead (vascular) dementia further contribute by impeding clearance of solutes out brain transport nutrients across barrier. Severe is an independent risk factor for cognitive decline. The clinical diagnosis based on assessment associated cerebrovascular perivascular spaces concentrations both Aβ(40) Aβ(42) cerebrospinal fluid prove be suggestive CAA. Transgenic mouse models overexpress human precursor show parenchymal CAA, corroborating current concept pathogenesis: neuronal enters drainage pathway accumulate vessel walls increased amounts and/or decreased Aβ, respectively. We suggest represents early impairment while with transendothelial Aβ. plays important role multimorbid condition ageing but its contribution neurodegeneration remains elucidated.

参考文章(185)
Tamas Revesz, Jorge Ghiso, Tammaryn Lashley, Gordon Plant, Agueda Rostagno, Blas Frangione, Janice L. Holton, Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View Journal of Neuropathology and Experimental Neurology. ,vol. 62, pp. 885- 898 ,(2003) , 10.1093/JNEN/62.9.885
Catriona A. McLean, Konrad Beyreuther, Colin L. Masters, Amyloid Aβ levels in Alzheimer's disease – A diagnostic tool and the key to understanding the natural history of Aβ? Journal of Alzheimer's Disease. ,vol. 3, pp. 305- 312 ,(2001) , 10.3233/JAD-2001-3305
Kurt A. Jellinger, Johannes Attems, Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica. ,vol. 105, pp. 14- 17 ,(2003) , 10.1007/S00401-002-0634-5
S. D. Preston, P. V. Steart, A. Wilkinson, J. A. R. Nicoll, R. O. Weller, Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain Neuropathology and Applied Neurobiology. ,vol. 29, pp. 106- 117 ,(2003) , 10.1046/J.1365-2990.2003.00424.X
Fangyi Zhang, Chris Eckman, Steven Younkin, Karen K. Hsiao, Costantino Iadecola, Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. The Journal of Neuroscience. ,vol. 17, pp. 7655- 7661 ,(1997) , 10.1523/JNEUROSCI.17-20-07655.1997
T. Iwatsubo, Takaomi C Saido, DM Mann, VM Lee, John Q Trojanowski, Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. American Journal of Pathology. ,vol. 149, pp. 1823- 1830 ,(1996)
Dan Xu, Chunhui Yang, Luning Wang, Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study Acta Neuropathologica. ,vol. 106, pp. 89- 91 ,(2003) , 10.1007/S00401-003-0706-1
P. Hedera, R. P. Friedland, D. R. D. Premkumar, R. N. Kalaria, D. L. Cohen, Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. American Journal of Pathology. ,vol. 148, pp. 2083- 2095 ,(1996)
Roy O. Weller, Adrian Massey, Tracey A. Newman, Margaret Hutchings, Yu-Min Kuo, Alex E. Roher, Cerebral Amyloid Angiopathy The American Journal of Pathology. ,vol. 153, pp. 725- 733 ,(1998) , 10.1016/S0002-9440(10)65616-7